Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes

被引:166
作者
Maksimoska, Jasna [1 ,2 ]
Feng, Li [3 ]
Harms, Klaus [3 ]
Yi, Chunling [1 ]
Kissil, Joseph [1 ]
Marmorstein, Ronen [1 ,2 ]
Meggers, Eric [3 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA
[3] Univ Marburg, Fachbereich Chem, D-35043 Marburg, Germany
基金
美国国家卫生研究院;
关键词
D O I
10.1021/ja805555a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A strategy for targeting protein kinases with large ATP-binding sites by using bulky and rigid octahedral ruthenium complexes as structural scaffolds is presented. A highly potent and selective GSK3 and Pim1 half-sandwich complex NP309 was successfully converted into a PAK1 inhibitor by making use of the large octahedral compounds Lambda-FL172 and Lambda-FL411 in which the cyclopentadienyl moiety of NP309 is replaced by a chloride and sterically demanding diimine ligands. A 1.65 angstrom cocrystal structure of PAK1 with Lambda-FL172 reveals how the large coordination sphere of the ruthenium complex matches the size of the active site and serves as a yardstick to discriminate between otherwise closely related binding sites.
引用
收藏
页码:15764 / +
页数:3
相关论文
共 10 条
[1]   Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach [J].
Bishop, AC ;
Kung, CY ;
Shah, K ;
Witucki, L ;
Shokat, KM ;
Liu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (04) :627-631
[2]   Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: Discovery of potent and selective protein kinase inhibitors [J].
Bregman, H ;
Carroll, PJ ;
Meggers, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (03) :877-884
[3]   Structural bioinformatics-based design of selective, irreversible kinase inhibitors [J].
Cohen, MS ;
Zhang, C ;
Shokat, KM ;
Taunton, J .
SCIENCE, 2005, 308 (5726) :1318-1321
[4]   An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase [J].
Deacon, Sean W. ;
Beeser, Alexander ;
Fukui, Jami A. ;
Rennefahrt, Ulrike E. E. ;
Myers, Cynthia ;
Chernoff, Jonathan ;
Peterson, Jeffrey R. .
CHEMISTRY & BIOLOGY, 2008, 15 (04) :322-331
[5]   Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins [J].
Frost, JA ;
Steen, H ;
Shapiro, P ;
Lewis, T ;
Ahn, N ;
Shaw, PE ;
Cobb, MH .
EMBO JOURNAL, 1997, 16 (21) :6426-6438
[6]   p21-activated kinases in cancer [J].
Kumar, Rakesh ;
Gururaj, Anupama E. ;
Barnes, Christopher J. .
NATURE REVIEWS CANCER, 2006, 6 (06) :459-471
[7]   Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch [J].
Lei, M ;
Lu, WG ;
Meng, WY ;
Parrini, MC ;
Eck, MJ ;
Mayer, BJ ;
Harrison, SC .
CELL, 2000, 102 (03) :387-397
[8]   The protein kinase complement of the human genome [J].
Manning, G ;
Whyte, DB ;
Martinez, R ;
Hunter, T ;
Sudarsanam, S .
SCIENCE, 2002, 298 (5600) :1912-+
[9]   Exploring chemical space with organometallics: Ruthenium complexes as protein kinase inhibitors [J].
Meggers, Eric ;
Atilla-Gokcumen, G. Ekin ;
Bregman, Howard ;
Maksimoska, Jasna ;
Mulcahy, Seann P. ;
Pagano, Nicholas ;
Williams, Douglas S. .
SYNLETT, 2007, (08) :1177-1189
[10]   Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition [J].
Tran, NH ;
Frost, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11221-11226